Key statistics
On Thursday, Shield Therapeutics PLC (STX:LSE) closed at 4.00, 276.47% above the 52 week low of 1.06 set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.25 |
---|---|
High | 4.00 |
Low | 4.00 |
Bid | 3.90 |
Offer | 4.30 |
Previous close | 4.25 |
Average volume | 3.16m |
---|---|
Shares outstanding | 782.06m |
Free float | 294.01m |
P/E (TTM) | -- |
Market cap | 33.24m GBP |
EPS (TTM) | -0.0477 GBP |
Data delayed at least 20 minutes, as of Sep 19 2024 16:35 BST.
More ▼
- Interim results
- ACCRUFeR® Approved by Health Canada
- Notice of interim results
- Unaudited Q2 2024 Trading Update
- Directorate Change
- $5.7m Milestone Monetization Agreement with AOP
- Results of 2024 Annual General Meeting
- New Drug Application for Accrufer® in South Korea
- Audited results for the year ended 31 Dec 2023
- Business Update for Q1 2024
More ▼